Covered Stocks

Shawn Egan

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Shawn Egan works at CITI and is covering the the Healthcare sector with 4 price targets and ratings documented since 2020 spanning on 1 stocks.

Shawn Egan's average stock forecast success ratio is 50% with an average time for price targets to be met of 78 days.

Most recent stock forecast was given on ARWR, Arrowhead Pharmaceuticals, Inc at 08-Feb-2021.

Wall Street Analyst Shawn Egan

Analyst best performing recommendations are on ARWR (ARROWHEAD PHARMACEUTICALS, INC).
The best stock recommendation documented was for ARWR (ARROWHEAD PHARMACEUTICALS, INC) at 11/19/2020. The price target of $90 was fulfilled within 78 days with a profit of $21.08 (30.59%) receiving and performance score of 3.92.

Average potential price target upside

Currently, out of the existing stock ratings of Shawn Egan - 2 which are a Buy (100%)

ARWR

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

60

$25.59 (74.37%)

60

8 days ago

6/12 (50%)

$17.17 (49.71%)

183

Buy

40

$5.59 (16.25%)

35

20 days ago

11/12 (91.67%)

$-8.2 (-13.11%)

131

Buy

90

$55.59 (161.55%)

90

3 months 22 days ago

0/5 (0%)

$46.67 (127.37%)

Buy

55

$20.59 (59.84%)

59

3 months 24 days ago

9/15 (60%)

$21.4 (46.97%)

129

Buy

52

$17.59 (51.12%)

55

3 months 25 days ago

21/32 (65.63%)

$18.37 (50.58%)

159

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

To continue looking at which analysts cover the stock please register to the basic or advanced membership